Arthritis of the temporomandibular joint
Conditions
Brief summary
Pain relief will be measured with 100 mm VAS-scale at baseline, 1, 3 and 6 months after treatment
Detailed description
The maximal mouth opening will be measured in mm at baseline, 1, 3 and 6 months after treatment with cortisoneinjection or arthrocentesis, Psychosocial factors measurements will be collected at base examination in the clinic and the patients will have to fill out a questionnaire containing The Patient Health Questionnaire (PHQ-9 and PHQ-15), GAD-7, PCS. In every visit JFLS and GCPS will be measured through another questionnaire., Presence of degenerative bone changes will be examined by oral radiologist and graded as 0 (no bony changes) or 1 (bone changes in the TMJ).
Interventions
DRUGlausn
DRUGPanodil 500 mg tabletter.
DRUGDepo-Medrol cum Lidocain 40 mg/ml / 10 mg/ml injektionsvätska
DRUGsuspension
Sponsors
Vaestra Goetalandsregionen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief will be measured with 100 mm VAS-scale at baseline, 1, 3 and 6 months after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| The maximal mouth opening will be measured in mm at baseline, 1, 3 and 6 months after treatment with cortisoneinjection or arthrocentesis, Psychosocial factors measurements will be collected at base examination in the clinic and the patients will have to fill out a questionnaire containing The Patient Health Questionnaire (PHQ-9 and PHQ-15), GAD-7, PCS. In every visit JFLS and GCPS will be measured through another questionnaire., Presence of degenerative bone changes will be examined by oral radiologist and graded as 0 (no bony changes) or 1 (bone changes in the TMJ). | — |
Countries
Sweden
Outcome results
None listed